Larimar Therapeutics, Inc. (LRMR) NASDAQ

4.19

+0.955(+29.57%)

Updated at October 01 02:54PM

Currency In USD

Valuation

Market Cap237.06M
Enterprise Value208.96M
P/E Ratio-2.69
PEG Ratio0.57
Price/Sales Ratio743.14
Price/Book Ratio2.24
Enterprise/Revenue710.01
Enterprise/EBITDA-3.16

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-207.02
Operating Margin-225.18

Management Effectiveness

Return On Assets-0.67
Return On Equity-0.63

Income Statement

Revenue0
Revenue/Share0.01
Gross Profit-318,000
EBITDA-80.29M
Net Income-80.6M
Diluted EPS-1.32

Balance Sheet

Total Cash138.52M
Total Cash/Share2.16
Total Debt4.61M
Total Debt/Equity0.04
Current Ratio5.46
Book Value Per Share1.87

Price History

52-Week Change-33.25
52-Week High9.5
52-Week Low1.61
Moving Average 50 Days3.89
Moving Average 200 Days3.18

Statistics

Average Volume2.01M
Shares Outstanding85.59M
% Held by Institutions94.11

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:12
Last Split DateMay 29, 2020